BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24978351)

  • 1. Low-dose acitretin in treatment of plaque-type psoriasis: descriptive study of efficacy and safety.
    Borghi A; Corazza M; Bertoldi AM; Caroppo F; Virgili A
    Acta Derm Venereol; 2015 Mar; 95(3):332-6. PubMed ID: 24978351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing acitretin use in patients with plaque psoriasis.
    Chiricozzi A; Panduri S; Dini V; Tonini A; Gualtieri B; Romanelli M
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 27998019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of acitretin in three fixed doses of 25, 35 and 50 mg in adult patients with severe plaque type psoriasis: a randomized, double blind, parallel group, dose ranging study.
    Dogra S; Jain A; Kanwar AJ
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e305-11. PubMed ID: 22816881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial.
    Gisondi P; Del Giglio M; Cotena C; Girolomoni G
    Br J Dermatol; 2008 Jun; 158(6):1345-9. PubMed ID: 18410408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acitretin: optimal dosing strategies.
    Ling MR
    J Am Acad Dermatol; 1999 Sep; 41(3 Pt 2):S13-7. PubMed ID: 10459141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, randomized, open-label pilot trial assessing the efficacy and safety of etanercept 50 mg twice weekly followed by etanercept 25 mg twice weekly, the combination of etanercept 25 mg twice weekly and acitretin, and acitretin alone in patients with moderate to severe psoriasis.
    Lee JH; Youn JI; Kim TY; Choi JH; Park CJ; Choe YB; Song HJ; Kim NI; Kim KJ; Lee JH; Yoo HJ
    BMC Dermatol; 2016 Jul; 16(1):11. PubMed ID: 27455955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and Safety of Acitretin in Children with Plaque Psoriasis: A Multicenter Retrospective Analysis.
    Di Lernia V; Bonamonte D; Lasagni C; Belloni Fortina A; Cambiaghi S; Corazza M; Di Nuzzo S; Gisondi P; Panzone M; Guarneri C; Neri I
    Pediatr Dermatol; 2016 Sep; 33(5):530-5. PubMed ID: 27443789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of oxymatrine for treatment and relapse suppression of severe plaque psoriasis: results from a single-blinded randomized controlled clinical trial.
    Zhou H; Shi HJ; Yang J; Chen WG; Xia L; Song HB; Bo KP; Ma W
    Br J Dermatol; 2017 Jun; 176(6):1446-1455. PubMed ID: 28112799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose acitretin is associated with fewer adverse events than high-dose acitretin in the treatment of psoriasis.
    Pearce DJ; Klinger S; Ziel KK; Murad EJ; Rowell R; Feldman SR
    Arch Dermatol; 2006 Aug; 142(8):1000-4. PubMed ID: 16924049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of calcipotriol + acitretin combination therapy for psoriasis: comparison with acitretin monotherapy.
    Rim JH; Park JY; Choe YB; Youn JI
    Am J Clin Dermatol; 2003; 4(7):507-10. PubMed ID: 12814339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of psoriasis with etretinate and acitretin: a follow up of actual use.
    Magis NL; Blummel JJ; Kerkhof PC; Gerritsen RM
    Eur J Dermatol; 2000; 10(7):517-21. PubMed ID: 11056421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of acitretin and commercial tanning bed therapy for psoriasis.
    Carlin CS; Callis KP; Krueger GG
    Arch Dermatol; 2003 Apr; 139(4):436-42. PubMed ID: 12707089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of low-dose acitretin in the treatment of psoriasis.
    Haushalter K; Murad EJ; Dabade TS; Rowell R; Pearce DJ; Feldman SR
    J Dermatolog Treat; 2012 Dec; 23(6):400-3. PubMed ID: 21787207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of combination Acitretin and Pioglitazone therapy in patients with moderate to severe chronic plaque-type psoriasis: a randomized, double-blind, placebo-controlled clinical trial.
    Mittal R; Malhotra S; Pandhi P; Kaur I; Dogra S
    Arch Dermatol; 2009 Apr; 145(4):387-93. PubMed ID: 19380660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug fever as an adverse effect of acitretin in complicated psoriasis patient.
    Rob F; Fialová J; Brejchová M; Džambová M; Sečníková Z; Zelenková D; Jiráková A; Hercogová J
    Dermatol Ther; 2015; 28(6):366-8. PubMed ID: 26133643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the efficacy of acitretin therapy for nail psoriasis.
    Tosti A; Ricotti C; Romanelli P; Cameli N; Piraccini BM
    Arch Dermatol; 2009 Mar; 145(3):269-71. PubMed ID: 19289755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythroderma in a patient taking acitretin for plaque psoriasis.
    Ahdout J; Mandel H; Chiu M
    J Drugs Dermatol; 2008 Apr; 7(4):391-4. PubMed ID: 18459522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Chinese herbal medicine combined with acitretin capsule in treating psoriasis of blood-heat syndrome type.
    Zhang LX; Bai YP; Song PH; You LP; Yang DQ
    Chin J Integr Med; 2009 Apr; 15(2):141-4. PubMed ID: 19407953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of acitretin in severe psoriasis.
    Geiger JM
    Skin Therapy Lett; 2003; 8(4):1-3, 7. PubMed ID: 12858231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoic acid syndrome in a patient with psoriasis.
    Liu D; Cao F; Yan X; Chen X; Chen Y; Tu Y; Furue M
    Eur J Dermatol; 2009; 19(6):632-4. PubMed ID: 19605343
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.